Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

  • López Ramos, María Goretti
  • Prieto Tato, Luis Manuel
  • Ramos Amador, José Tomás
  • Noguera Julian, Antoni
In 2010, the WHO recommended an increase in the daily doses of first-line anti-tuberculosis medicines in children. We aim to characterize the pharmacokinetics of the once-daily isoniazid (INH) dose at 10 mg/kg of body weight in infants <6 months of age. We performed a multicenter pharmacokinetic study in Spain. The N-acetyltransferase 2 gene was analyzed to determine the acetylation status. Samples were analyzed using a validated UPLC-UV assay. A non-compartmental pharmacokinetic analysis was performed. Twenty-three pharmacokinetic profiles were performed in 20 infants (8 females) at a median (IQR) age of 19.0 (12.6–23.3) weeks. The acetylator statuses were homozygous fast (n = 1), heterozygous intermediate (n = 12), and homozygous slow (n = 7). INH median (IQR) Cmax and AUC0–24h values were 4.8 (3.7–6.7) mg/L and 23.5 (13.4–36.7) h*mg/L and the adult targets (>3 mg/L and 11.6–26.3 h*mg/L) were not reached in three and five cases, respectively. The age at assessment or acetylator status had no impact on Cmax values, but a larger INH AUC0–24h (p = 0.025) and trends towards a longer half-life (p = 0.055) and slower clearance (p = 0.070) were observed in homozygous slow acetylators. Treatment was well tolerated; mildly elevated alanine aminotransferase levels were observed in three cases. In our series of young infants receiving isoniazid, no major safety concerns were raised, and the target adult levels were reached in most patients.
Repisalud
Publicación Artículo científico (JournalArticle)

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

  • Restrepo, Clara
  • Gutiirrez-Rivas, Monica
  • Pacheco, Yolanda María
  • García, Marcial
  • Blanco, Julià
  • Medrano, Luz Maria
  • Navarrete-Muñoz, María A
  • Gutiérrez, Félix
  • Miralles, Pilar
  • Dalmau, David
  • Gómez, Juan Luis
  • Górgolas, Miguel
  • Cabello, Alfonso
  • Resino, Salvador
  • Benito, José Miguel
  • Rallón, Norma
OBJECTIVE: We investigated the association of genetic polymorphisms in chemokine and chemokine receptor genes with poor immunological recovery in HIV patients starting combined antiretroviral therapy (cART) with low CD4 T-cell counts. METHODS: A case-control study was conducted in 412 HIV-infected patients starting cART with CD4 T-cell count <200 cells/μL and successful viral control for two years. CD4 count increase below 200 cells/μL after two years on cART was used to define INR (immunological non-responder) patients. Polymorphisms in CXCL12, CCL5 and CCR2 genes were genotyped using sequenom's MassARRAY platform. RESULTS: Thirty two percent (134/412) of patients were classified as INR. After adjusting by age, route of HIV infection, length of infection before cART and viral hepatitis coinfection, CCR2 rs1799864-AG genotype was significantly associated with INR status (OR [95% CI]: 1.80 [1.04-3.11]; p = 0.04), and CXCL12 rs1801157-TT genotype showed a trend (OR [95% CI]: 2.47 [0.96-6.35]; p = 0.06). CONCLUSIONS: CCR2 rs1799864-AG or CXCL12 rs1801157-TT genotypes influence on the probability of poor CD4 recovery in the population of HIV patients starting cART with low CD4 counts. Genotyping of these polymorphisms could be used to estimate the risk of poor CD4 restoration, mainly in patients who are diagnosed late in the course of infection.
Dipòsit Digital de Documents de la UAB
Publicación

FcγRIIb-BCR co-ligation inhibits B-cell receptor signaling in chronic lymphocytic leukemia

  • Bosch, Rosa|||0000-0002-7596-183X
  • Mora, Alba|||0000-0003-1064-8495
  • Cuellar, Carolina
  • Ferrer, Gerardo|||0000-0002-4084-6815
  • Gorlatov, Sergey
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Montserrat, Emili
  • Sierra, Jorge|||0000-0002-7966-0356
  • Rai, Kanti R.
  • Chiorazzi, Nicholas
  • Moreno, Carol|||0000-0003-3275-0271
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy

  • Rodríguez-Gallego, Esther|||0000-0002-6363-2510
  • Gómez, Josep|||0000-0002-0573-7621
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Ferrando-Martínez, Sara
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Veloso Esteban, Sergio|||0000-0001-7943-1169
  • López-Dupla, Miguel
  • Beltrán-Debón, Raúl|||0000-0001-9691-1906
  • Alba, Verónica|||0000-0002-5925-9573
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Castellano, Alfonso J.
  • Leal, Manuel
  • Pacheco, Yolanda M.|||0000-0002-9451-8083
  • Ruiz-Mateos, Ezequiel|||0000-0001-6747-7813
  • Gutiérrez, Félix|||0000-0002-9485-6867
  • Vidal, Francesc|||0000-0002-6692-6186
  • Rull, Anna|||0000-0002-8907-7754
Dyslipidemia in HIV-infected patients is unique and pathophysiologically associated with host factors, HIV itself and the use of antiretroviral therapy (ART). The use of nuclear magnetic resonance spectroscopy (NMR) provides additional data to conventional lipid measurements concerning the number of lipoprotein subclasses and particle sizes. To investigate the ability of lipoprotein profile, we used a circulating metabolomic approach in a cohort of 103 ART-naive HIV-infected patients, who were initiating non-nucleoside analogue transcriptase inhibitor (NNRTI)-based ART, and we subsequently followed up these patients for 36 months. Univariate and multivariate analyses were performed to evaluate the predictive power of NMR spectroscopy. VLDL-metabolism (including VLDL lipid concentrations, sizes, and particle numbers), total triglycerides and lactate levels resulted in good classifiers of dyslipidemia (AUC 0.903). Total particles/HDL-P ratio was significantly higher in ART-associated dyslipidemia compared to ART-normolipidemia (p = 0.001). Large VLDL-Ps were positively associated with both LDL-triglycerides (ρ 0.682, p < 0.001) and lactate concentrations (ρ 0.416, p < 0.001), the last one a marker of mitochondrial low oxidative capacity. Our data suggest that circulating metabolites have better predictive values for HIV/ART-related dyslipidemia onset than do the biochemical markers associated with conventional lipid measurements. NMR identifies changes in VLDL-P, lactate and LDL-TG as potential clinical markers of baseline HIV-dyslipidemia predisposition. Differences in circulating metabolomics, especially differences in particle size, are indicators of important derangements of mitochondrial function that are linked to ART-related dyslipidemia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

  • Masiá, Mar|||0000-0001-9878-2458
  • Padilla Urrea, Sergio|||0000-0002-8420-7310
  • Moreno, Santiago|||0000-0002-2843-1094
  • Barber, Xavier|||0000-0003-3079-5855
  • Iribarren, Jose A.
  • Del Romero, Jorge
  • Gómez-Sirvent, Juan L.
  • Rivero, María
  • Vidal, Francesc|||0000-0002-6692-6186
  • Campins, Antonio A.
  • Gutiérrez, Félix|||0000-0002-9485-6867
  • Del Amo, Julia|||0000-0002-3104-540X
  • Dalmau, David|||0000-0003-1936-478X
  • Navarro, Maria Luisa
  • González, Maria Isabel
  • Soriano, Vicente|||0000-0002-4624-5199
  • Garcia, Federico
  • Rubio, Rafael
  • Iribarren, José Antonio
  • Hernández, Beatriz
  • Berenguer, Juan|||0000-0001-8541-8200
  • Sobrino, Paz
  • Hernando, Victoria
  • Alejos, Belén
  • Álvarez, Débora
  • Monge, Susana|||0000-0003-1412-3012
  • Jarrín, Inma|||0000-0002-7485-2252
  • Rivero, Yaiza
  • González, Cristina
  • Muñoz-Fernández, M.Ängeles
  • García-Merino, Isabel
  • Rico, Coral Gómez
  • de la Fuente, Jorge Gallego
  • Torre, Almudena García
  • Portilla, Joaquín|||0000-0002-3676-9511
  • Merino, Esperanza
  • Reus, Sergio|||0000-0002-3320-9754
  • Boix, Vicente|||0000-0002-7015-3948
  • Giner, Livia|||0000-0002-1885-3736
  • Gadea, Carmen
  • Portilla, Irene
  • Pampliega, Maria
  • Díez, Marcos
  • Rodríguez, Juan Carlos
  • Sánchez Payá, José
  • Podzamczer, Daniel|||0000-0001-7090-3561
  • Imaz, Arkaitz|||0000-0001-8411-1952
  • Van Den Eyncle, Evan
  • Di Yacovo, Silvana
  • Sumoy, Maria
  • Gómez, Juan Luis
  • Rodríguez, Patricia
  • Alemán, María Remedios
  • del Mar Alonso, María
  • Hernández, María Inmaculada
  • Díaz-Flores, Felicitas
  • García, Dácil
  • Pelazas, Ricardo
  • Labarga, Pablo
  • Barreiro, Pablo|||0000-0002-3819-5371
  • Rivas, Pablo
  • Blanco, Francisco
  • Carbonero, Luz Martín
  • Vispo, Eugenia
  • Solera, Carmen
  • Asensi, Víctor
  • Valle, Eulalia
  • Cartón, José Antonio
  • Pérez, Vicente Estrada
  • Molina, María Jesús Téllez
  • García, Jorge Vergas
  • Carrera, Elisa Pérez-Cecilia
  • Pulido, Federico|||0000-0002-7414-8812
  • Bisbal, Otilia|||0000-0003-3746-3378
  • Matarranz, Mariano
  • Lagarde, Maria
  • Rubio-Martín, Rafael
  • Hernando, Asunción|||0000-0002-1901-1119
  • Portillo, Angel
  • Arrizabalaga, Julio
  • Aramburu, María José
  • Camino, Xabier
  • Rodríguez-Arrondo, Francisco
  • Von Wichmann, Miguel Ángel
  • Tomé, Lidia Pascual
  • Goenaga, Miguel Ángel
  • Bustinduy, M.J.
  • Galparsoro, H.A.
  • Ibarguren, M.
  • Aguado, Mirian
  • Masiá, M.
  • Fernández, Marta
  • García, Elena
  • Navarro, Andrés
  • Montolio, Fernando
  • Robledano, C.
  • Colomé, J.G.
  • Adsuar, Araceli
  • Pascual, R.
  • Muga, Roberto|||0000-0001-6301-431X
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • López Bernaldo de Quirós, Juan Carlos|||0000-0002-8989-9758
  • Miralles, Pilar
  • Gutiérrez, Isabel
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Padilla Ortega, Belén
  • Gijon, Paloma|||0000-0002-5011-1927
  • Carrero, Ana
  • Aldámiz-Echevarría Lois, Maria Teresa|||0000-0002-4374-6940
  • Tejerina, Francisco|||0000-0002-4136-3575
  • Parras, Francisco José
  • Balsalobre, Pascual
  • Diez, Cristina
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Veloso, S.
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • López-Dupla, M.
  • Olona, Montserrat|||0000-0001-5303-9361
  • Aguilar, Alba
  • Sirvent, J.J.
  • Alba, Verónica|||0000-0002-5925-9573
  • Calavia, O.
  • Montero, M.
  • Lacruz, José
  • Blanes, M.
  • Calabuig, Eva|||0000-0002-0177-0037
  • Cuellar, S.
  • López, J.
  • Salavert, Miguel|||0000-0002-8571-2124
  • González García, Juan|||0000-0002-3652-002X
  • Bernardino, José Ignacio|||0000-0003-3501-8529
  • Arribas, Jose|||0000-0002-7410-9450
  • Montes, María Luisa|||0000-0003-1748-813X
  • Peña, Jose M.
  • Arribas, Blanca
  • Castro, Juan Miguel
  • Zamora, Francisco
  • Pérez, I.
  • Estébanez, Miriam
  • García Bujalance, Silvia
  • Díaz, Marta
  • Alcáriz, Natalia Stella
  • Mingorance, Jesús|||0000-0001-6173-5711
  • Montero, Dolores
  • González Baeza, Alicia
  • José, Maria Isabel de
  • de los Santos Gil, Ignacio|||0000-0001-7073-5211
  • Sanz Sanz, Jesús
  • Salas, A.
  • Sarriá, C.
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Oteo, José A.|||0000-0001-7080-6542
  • Blanco, José Ramón|||0000-0002-4268-0150
  • Ibarra, V.
  • Metola, L.
  • Sanz, M.
  • Pérez-Martínez, L.
  • Pascual, A.
  • Ramos, C.
  • Arazo, P.
  • Gil, D.
  • Rivero, Montserrat|||0000-0002-5834-1559
  • Casado, M.I.
  • Díaz, J.A.
  • Uriz, J.
  • Repáraz, J.
  • Irigoyen, C.
  • Arraiza, M.J.
  • Segura, Ferrán
  • Amengual Guedan, Maria Jose|||0000-0002-5385-3061
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Sala, Montserrat
  • Cervantes Garcia, Manuel|||0000-0001-6073-1110
  • Pineda, Valentí
  • Segura, Victor
  • Navarro Vilasaro, Marta|||0000-0002-3784-4405
  • Antón, Esperanza
  • Nogueras, Maria-Mercedes|||0000-0001-5925-1929
  • Casado, José Luis|||0000-0002-7639-8591
  • Dronda, Fernando|||0000-0002-0443-5816
  • Moreno, Ana
  • Pérez Elías, Mª Jesus|||0000-0001-5700-5257
  • López, D.
  • Gutiérrez, Carolina
  • Madrid, N.
  • Lamas, A.
  • Martí, P.
  • De Diaz, A.
  • Serrrano, S.
  • Donat, Lucas
  • Cano, Amanda|||0000-0001-9567-4283
  • Bernal, Enrique|||0000-0002-4041-0579
  • Muñoz, Á.
  • García, F.
  • Hernández Quero, José
  • Peña, Alejandro
  • Muñoz Medina, Leopoldo|||0000-0001-8995-8271
  • Parra, J.
  • Alvarez, Mar|||0000-0003-4590-4401
  • Chueca, Natalia|||0000-0002-3420-3290
  • Guillot, V.
  • Vinuesa, David|||0000-0002-5663-8447
  • Fernández, J.A.
  • Rodríguez, Carmen
  • Puerta, T.
  • Carrió, J.C.
  • Vera, M.
  • Ballesteros, J.
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Sambeat, Maria Antonia
  • Lamarca, Karuna|||0000-0001-5292-2216
  • Mateo, María Gracia|||0000-0003-1389-9310
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Fernández-Duran, Irene|||0000-0003-1289-7276
  • Antela, A.
  • Losada, E.
  • Riera, M.
  • Peñaranda, María|||0000-0001-6290-3457
  • Leyes, M.
  • Ribas, M.A.
  • Campins, A.A.
  • Vidal, Carmen|||0000-0003-2768-2710
  • Gil, L.
  • Fanjul, F.
  • Marinescu, C.
  • Ribera, Esteban|||0000-0002-3752-8808
  • Santos, J.
  • Márquez, M.
  • Viciana, I.
  • Palacios, Rosario
  • González, C.M.
  • Viciana, P.
  • Leal, Manuel
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Trastoy, M.
  • Espinosa, Nuria|||0000-0003-2249-2352
Outcomes of people living with HIV (PLWH) developing non-AIDS events (NAEs) remain poorly defined. We aimed to classify NAEs according to severity, and to describe clinical outcomes and prognostic factors after NAE occurrence using data from CoRIS, a large Spanish HIV cohort from 2004 to 2013. Prospective multicenter cohort study. Using a multistate approach we estimated 3 transition probabilities: from alive and NAE-free to alive and NAE-experienced ("NAE development"); from alive and NAE-experienced to death ("Death after NAE"); and from alive and NAE-free to death ("Death without NAE"). We analyzed the effect of different covariates, including demographic, immunologic and virologic data, on death or NAE development, based on estimates of hazard ratios (HR). We focused on the transition "Death after NAE". 8,789 PLWH were followed-up until death, cohort censoring or loss to follow-up. 792 first incident NAEs occurred in 9.01% PLWH (incidence rate 28.76; 95% confidence interval [CI], 26.80-30.84, per 1000 patient-years). 112 (14.14%) NAE-experienced PLWH and 240 (2.73%) NAE-free PLWH died. Adjusted HR for the transition "Death after NAE" was 12.1 (95%CI, 4.90-29.89). There was a graded increase in the adjusted HRs for mortality according to NAE severity category: HR (95%CI), 4.02 (2.45-6.57) for intermediate-severity; and 9.85 (5.45-17.81) for serious NAEs compared to low-severity NAEs. Male sex (HR 2.04; 95% CI, 1.11-3.84), age.